perindopril has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, H; Noguchi, R; Yoshiji, H | 1 |
| Fujimoto, M; Fukui, H; Ikenaka, Y; Kaji, K; Kitade, M; Kojima, H; Mitoro, A; Noguchi, R; Toyohara, M; Uemura, M; Yamao, J; Yamazaki, M; Yoshiji, H | 1 |
1 trial(s) available for perindopril and Chronic Hepatitis C
| Article | Year |
|---|---|
Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Disease Progression; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Perindopril; Transforming Growth Factor beta | 2006 |
1 other study(ies) available for perindopril and Chronic Hepatitis C
| Article | Year |
|---|---|
Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C.
Topics: Alanine Transaminase; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Perindopril; RNA, Viral | 2005 |